Qiang, Li
Dougan, Stephanie K. http://orcid.org/0000-0002-2263-363X
Article History
First Online: 15 December 2022
Competing interests
: S.K.D. receives research funding from Novartis Pharmaceuticals, Genocea and Bristol-Myers Squibb, and is a founder, science advisory board member and equity holder in Kojin.